Imatinib mesylate, a selective tyrosine kinase inhibitor, induced a sustained objective response in treating gastrointestinal stromal tumors with the inhibition of the KIT signal-transduction pathway.
More Information Supplier PageImatinib mesylate, a selective tyrosine kinase inhibitor, induced a sustained objective response in treating gastrointestinal stromal tumors with the inhibition of the KIT signal-transduction pathway.
More Information Supplier PageImatinib mesylate, a selective tyrosine kinase inhibitor, induced a sustained objective response in treating gastrointestinal stromal tumors with the inhibition of the KIT signal-transduction pathway.
More Information Supplier PageIloperidone is an atypical antipsychotic for the treatment of schizophrenia.
More Information Supplier PageIloperidone is an atypical antipsychotic for the treatment of schizophrenia.
More Information Supplier PageIloperidone is an atypical antipsychotic for the treatment of schizophrenia.
More Information Supplier PageIloperidone is an atypical antipsychotic for the treatment of schizophrenia.
More Information Supplier PageIloperidone is an atypical antipsychotic for the treatment of schizophrenia.
More Information Supplier PageImiquimod (Aldara) is a a heterocyclic imidazoquinoline amide that acts as an immune response modifier.
More Information Supplier PageImiquimod (Aldara) is a a heterocyclic imidazoquinoline amide that acts as an immune response modifier.
More Information Supplier Page
